x min read

News Roundup: GlaxoSmithKline plc (NYSE:GSK), The Boeing Company (NYSE:BA), Abbott Laboratories (NYSE:ABT)

News Roundup: GlaxoSmithKline plc (NYSE:GSK), The Boeing Company (NYSE:BA), Abbott Laboratories (NYSE:ABT)
Written by
Ryan Mitchell
Published on
October 27, 2014
Copy URL
Share on LinkedIn
Share on Reddit
Share on Twitter/X
Share on Facebook
InsidrFinancial

GlaxoSmithKline plc (NYSE:GSK) recently released third quarter earnings of GBP0.28 a share, GBP0.04 improved than the Capital IQ Consensus anticipates of GBP0.24; revenues plunged 3% (ex-divestments) year/year to GBP5.65B as compared to the GBP5.75B consensus. Shares of GlaxoSmithKline plc (NYSE:GSK) traded at $45.79 by surging 0.95% with price volatility of 1.19% for a week and 1.24% for a month. Its beta stands at 0.65 times.The Boeing Company (NYSE:BA) inched up in last session as the firm recently posted that its third quarter earnings of $2.14 a share, excluding non-recurring items, $0.18 improved than the Capital IQ Consensus anticipates of $1.96; revenues surged 7.5% year/year to $23.78B as compared to the $23.05B consensus. The Boeing Company (NYSE:BA) stock hit highest price at $122.8399, beginning with a price of $122.20 and reported a gain of 0.17% to the closed at $122.24 with a day range of $121.26-$122.8399. The total market capitalization remained 87.149 Billion, total volume of 4.01 Million shares held in the session was surprisingly higher than its average volume of 4239.59 shares.Abbott Laboratories (NYSE:ABT) slightly up 0.07% on Friday as the healthcare firm reported that its third quarter earnings of $0.62 a share, excluding non-recurring items, $0.02 better than the Capital IQ Consensus of $0.60. Third-quarter global sales of $5.1B from continuing operations, which keep out the sales from the developed markets branded generics pharmaceuticals business selling to Mylan (MYL), moved up 6.7% on an operational basis and 5.8 percent on a reported basis. Abbott Laboratories (NYSE:ABT) stock has highest price of $42.67 in last session, beginning with a price of $42.34 and reported a gain of 0.07% to the closed at $42.46 with a day range of $42.12-$42.67. The stock is going forward its 52-week low with 21.10% and moving down from its 52 week high price with -3.43%.

Discover Hidden Gems

Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.